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treatment of non-severe pneumonia' Lancet Infections vol 9 no 3. pp185
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) 
Among the under 5-year-olds worldwide there are 
about 156,000,000 cases of pneumonia each year. 
This causes about 20% of all deaths in this age 
group. Effective implementation of the WHO 
Integrated Management of Childhood Illness (IMCI) 
reduces this morbidity and mortality. The 
recommendations for treating pneumonia for first-
level health facilities were made over ten years ago 
although there was an update in 2005  
In last 10 years there have been advances in: 
 our knowledge of the epidemiology of 
pneumonia and resistance to antimicrobials  
 the development of a greater range of 
antimicrobials.  
Hence there is a need for a review of the guidelines 
for management. A team of experts in this subject 
has undertaken an in-depth review of published 
medical research and their conclusions are 
summarised below under the following headings:  
1. What is the most appropriate first-line 
antimicrobial?  
2. How to diagnose treatment failure. 
3. Why treatment fails and what to do. 
 
1. What is the most appropriate first-line 
antimicrobial?  
Give: 
 Amoxicillin 50mg/kg per day in two divided 
oral doses for three days but 
 If there is a high prevalence of HIV in the 
area then give amoxicillin 50mg/kg in two 
divided doses for five days. This longer course 
of treatment is advised because of the lack of 
evidence for the effectiveness of the shorter 
course and the fact that the risk of severe 
pneumonia is greater in the HIV infected group. 
 Co-trimoxazolea may still be used (8mg 
trimethoprim /kg per day in two divided oral 
doses) if the resistance to this drug is known to 
be low. 
 
Guidelines for treatment are useful but only after the 
clinical situation has been properly assessed and a 
judgement made about the severity of pneumonia. 
The features of non-severe pneumonia in 
childhood are based upon: 
 Cough or 
                                                     
a Co-trimoxazole contains trimethoprim and sulphamethoxazole 
in the ratio of 1 part to 5 parts. It should generally be avoided in 
infants under age 6 weeks. 
 
 Breathing difficulty. 
 Tachypnoea: breathing rate of over 40/minute 
in a child aged 12 – 59 months and over 
50/minute in a child 2 – 11 months. 
Referral to hospital is needed for severe or very 
severe pneumonia, which is indicated by: 
 Lower chest undraping or 
 Cyanosis 
 Stridor when calm 
 Inability to feed 
 Convulsions 
 Persistent vomiting 
 Lethargy 
 Unconsciousness. 
Children under age two months have a high 
mortality from pneumonia and so all in this age 
group must be placed in the severe category. 
 
The causative organisms for severe pneumonia vary 
in their proportions between and within countries. 
Studies in resource-poor countries are sparse. 
Nevertheless it remains important to target the most 
likely organisms that may lead to severe pneumonia 
and these are: 
 Streptococcus pneumoniae in probably 17% - 37% of 
cases 
 Haemophilus influenzae in probably up to 31% of 
cases. 
However in perhaps 25% of cases of pneumonias 
acquired in the community are viral based. But this 
does not mean that a bacterial infection does not co-
exist. 
2. How to diagnose treatment failure 
The detection of treatment failure is needed as this 
may indicate a need to change antimicrobial therapy 
and/or to refer the patient to hospital. If the clinical 
features listed above under 'Referral to hospital is 
needed' are noted at 72 hours (48 hours in an area of 
high HIV incidence) then treatment failure is likely. 
3. Why treatment fails and what to do 
A clinical assessment will often give useful clues to a 
likely cause of treatment failure. The following list of 
many of the causes should be considered: 
 Causative bacterium is not sensitive to the 
antimicrobial prescribed 
 Inability or unwillingness to take the prescribed 
drug 
 Drug vomited and not replaced 
 Smaller dose than a child needed 
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 Alternative diagnosis or coexisting conditions 
such as: 
 Anaemia 
 HIV infection – see below 
 Malaria - see below 
 Bronchial asthma 
 Foreign body 




 Viral infection 
 Tuberculosis 
 Tuberculosis 
 Staphylococcus aureus infection or mycoplasma 
pneumoniae 
 H1N1 
There are many rare causes (e.g. fungal infections) 
that have not been included. 
 
Most cases of treatment failure should be referred to 
hospital, if possible. When this is done it is essential 
to send with the patient a short note about the 
clinical status at the time of referral and the 
treatment already given.  
Where HIV prevalence is high 
Where HIV infection rates exceed 5% the risk of 
pneumonia is increased and mortality is high. All 
children with pneumonia in these areas  should be 
assessed for HIV infection and appropriately tested. 
There are reports of 85% of pneumonia deaths 
occurring in HIV-positive children. The prophylactic 
use of co-trimoxazole for these children reduces the 
pneumonia-related death rate. If a child is already 
taking prophylactic co-trimoxazole and has non-
severe pneumonia amoxicillin is still indicated. 
Where malaria prevalence is high 
In children the clinical distinction between malaria 
and pneumonia can be difficult. Also a child with 
pneumonia may coincidentally also have malaria 
parasites on a blood slide. So if malaria cannot be 
excluded and pneumonia is still probable then 
treatment for malaria and pneumonia should be 
given together. A child who has malaria may develop 
severe anaemia that in turn leads to a tachypnoea. All 
patients should be checked for anaemia preferably by 
the laboratory but if this is not possible then look for 
pallor of the 
 Palms of the hands 
 Nail beds 
 Conjunctivae and 
 Mucous membranes. 
If severe anaemia is present then urgent hospital 
referral is essential. 
When transfer to hospital is impossible 
Although clinically indicated it may not be possible 
to transfer a patient to a place where a higher level of 
clinical care is available. Under these circumstances 
the child should be given antimicrobial treatment 
that covers a wider range of possible causative 
organisms. The drugs to consider are injectable: 
 chloramphenicol 
 ceftrioxone 
 penicillin and gentamicin. 
 
Key learning points 
 Amoxicillin is the first choice in the treatment 
of non-severe pneumonia in children less than 5 
years and not allergic to penicillin. Consider 
Erythromycin for children allergic to penicillin 
and those older than 5 years. 
 Be aware of the clinical features of severe 
pneumonia and treatment failure. 
 Consider the list of causes of treatment failure. 
 Never forget malaria and 
 Anaemia. 
 Pay special attention to the possibility of HIV 
infection in a child with recurrent non-severe 
pneumonia 
 Tachypnoea alone is an important clinical sign 
to assess the severity of pneumonia. 
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Thanks to Dr Louis Danga for reviewing this 
article. 
 
Quiz – see answers on page 17 
1. World wide how many children die: 
In their first month? 
Before their first birthday? 
Before their fifth birthday? 
2. What percent of children dying before their 






3. In what percent of under-five year old deaths 
is malnutrition the underlying cause of death? 
